Tharimmune, Inc. Enters Material Definitive Agreement
Ticker: CNTN · Form: 8-K · Filed: Oct 6, 2025 · CIK: 1861657
| Field | Detail |
|---|---|
| Company | Tharimmune, INC. (CNTN) |
| Form Type | 8-K |
| Filed Date | Oct 6, 2025 |
| Risk Level | medium |
| Pages | 1 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, corporate-action
TL;DR
Tharimmune just signed a big deal, filing an 8-K on Oct 1st.
AI Summary
On October 1, 2025, Tharimmune, Inc. entered into a material definitive agreement. The company, formerly known as Hillstream BioPharma Inc., is incorporated in Delaware and has its principal executive offices in Red Bank, NJ.
Why It Matters
This filing indicates a significant development for Tharimmune, Inc., potentially involving a new partnership, acquisition, or other crucial business transaction.
Risk Assessment
Risk Level: medium — Entering into a material definitive agreement can introduce new risks and opportunities, the specifics of which are not detailed in this initial filing.
Key Numbers
- 001-41210 — SEC File Number (Identifies the company's filing with the SEC.)
- 84-2642541 — I. R. S. Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- Tharimmune, Inc. (company) — Registrant
- October 1, 2025 (date) — Date of earliest event reported
- Hillstream BioPharma Inc. (company) — Former name
- Delaware (jurisdiction) — State of incorporation
- Red Bank, NJ (location) — Address of principal executive offices
FAQ
What is the nature of the material definitive agreement entered into by Tharimmune, Inc. on October 1, 2025?
The filing does not specify the nature of the material definitive agreement, only that one was entered into on October 1, 2025.
What was Tharimmune, Inc. formerly known as?
Tharimmune, Inc. was formerly known as Hillstream BioPharma Inc.
In which state is Tharimmune, Inc. incorporated?
Tharimmune, Inc. is incorporated in Delaware.
What is the principal executive office address for Tharimmune, Inc.?
The principal executive office address for Tharimmune, Inc. is 34 Shrewsbury Avenue, Suite 1C, Red Bank, NJ 07701.
What is the SEC file number for Tharimmune, Inc.?
The SEC file number for Tharimmune, Inc. is 001-41210.
Filing Stats: 388 words · 2 min read · ~1 pages · Grade level 11.5 · Accepted 2025-10-06 08:24:56
Key Financial Figures
- $0.0001 — nge on which registered Common stock, $0.0001 par value THAR The Nasdaq Stock Mar
Filing Documents
- form8-k.htm (8-K) — 33KB
- 0001493152-25-017018.txt ( ) — 196KB
- thar-20251001.xsd (EX-101.SCH) — 3KB
- thar-20251001_lab.xml (EX-101.LAB) — 33KB
- thar-20251001_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: October 6, 2025 Tharimmune, Inc. /s/ Sireesh Appajosyula Sireesh Appajosyula Chief Executive Officer -3-